Wikidata

(Q61956348)

English

A Study to Assess the Relative Bioavailability of Different Formulations of GSK2018682, a Sphingosine-1-phosphate Receptor Subtype 1 Agonist, in Healthy Volunteers.

clinical trial

In more languages

Statements

short name
P1A114919 (English)
0 references
title
An Open-label, Randomised, Crossover Study to Assess the Relative Bioavailability of Different 2mg Formulations of GSK2018682(S1P1 Agonist) in Healthy Volunteers (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
sponsor
GSK
0 references
country
Australia
0 references
start time
22 December 2010
0 references
end time
15 February 2011
0 references
number of participants
16
0 references
research site
GSK
0 references
minimum age
18 year
0 references
maximum age
55 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61956348&oldid=2114856914"